Gefticip 250mg

However, the emergence of immunotherapy has brought new hope to the field of lung cancer treatment. Unlike traditional chemotherapy, which targets rapidly dividing cells, immunotherapy targets specific proteins on the surface of cancer cells, known as immune checkpoint proteins, to prevent cancer cells from evading detection by the immune system. While the use of immunotherapy in lung cancer treatment is still in its early stages, the potential benefits are significant. By harnessing the power of the immune system to recognize and attack cancer cells, immunotherapy has the potential to improve outcomes for patients with advanced-stage NSCLC. As research in this area continues to evolve, we can expect to see further advancements in the use of immunotherapy for lung cancer treatment.